Aegros Company Profile, Contacts & Intelligence

Aegros Overview

At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.

Headquarters

Nsw, Au

Website

aegros.com.au

Industry

Biotechnology Research

Founded

2017

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

Aegros Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Aegros People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Aegros Workforce Composition

Seniority breakdown across 24 visible profiles.

Aegros Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to Aegros

Explore companies in related markets and compare their industry and employee estimates.